"ChemGenex Receives a Complete Response Letter from the FDA for OMAPRO(TM)"
What a statement! Why not Publish the KEY aspects of the "complete Response" Reason: There is something it the FDA letter maagement do not like investors to know!
This announcement comes out just a day after te company had a meeting with FDA (9 April)on validation of a Diagnostic. No mention of the result of this meeting......
This process will take time; possibly a long time. Do not discount the possibility of another capital raising.
Don't forget, this company was poised to commence major expeniture in maketing and distribution of this product in the USA, that is not cheap, and the cost of having new resources on standbuy will cost CXS dearly....
They should publish all the relevant information so investors can make an informed investment decision on CXS.
"ChemGenex Receives a Complete Response Letter from the FDA for...
Add to My Watchlist
What is My Watchlist?